Clinical Trials: A Phase 2 Trial of MLN8237, an Oral Aurora A Kinase Inhibitor, in Adult Patients With Aggressive Non-Hodgkin's Lymphoma
Sponsor and Collaborators
Millennium Pharmaceuticals, Inc.
For an updated listing of recruitment sites contact: Millennium Medical and Drug Information Center
Medical Monitor Millennium Pharmaceuticals, Inc.